Five new innovations join CO-AX Accelerator at Sahlgrenska Science Park
The new cohort brings together startups working across regulatory, therapeutics, drug discovery & development, precision oncology strengthening the life science and healthtech ecosystem at Sahlgrenska Science Park.
Strengthening the ecosystem through new companies
The new cohort reflects the breadth of innovation emerging within life science and healthtech, spanning advanced diagnostics and therapeutics, Cardiac health, AI-supported clinical decision-making and digital platforms for healthcare research.
The selected companies are developing solutions addressing challenges across precision oncology, diagnosis, treatment and clinical workflows. Through CO-AX Accelerator, they gain access to tailored business support, industry expertise and a strong cross-sector network.
The companies joining the CO-AX Accelerator
Silico builds agents and AI surrogates of the system so scientists can interrogate behavior before spending lab time. For HPLC, that means recovering precedent, predicting retention windows, and stating the next validation run.
Simulated separation
Zero waste
Precision
ReAlign helps you stay on top of your treatment with smart tracking, real-time insights, and a supportive community. Whether you're bracing, doing physio, or post-surgery — they've got you covered.
Gamified Treatment
Real-World Incentives
Community
Progress Visibility
AI4ra - AI for Regulatory affairs
AI4ra is Reimagining regulatory affairs documentation with AI for biotech & pharma - saving time & money so innovative drugs reach to patients faster.
Smart Document Generation
Accelerated Submissions
Strategic Work
Lower Costs
Lifelink
Lifelink is focused on creating a more accessible and user-friendly AED to enhance emergency response. The device will incorporate innovative features designed to improve its efficiency and integration with healthcare systems.
User-friendly AED
Accessible
Cost saving
K-Stem is the only workflow that simultaneously captures four distinct omic layers from the same individual cell in a microfluidic-free system that makes high-resolution profiling scalable, cost-effective, and low-labor.
Microfluidic-Free
Scalable
Cost-Effective
Low Labor
Clinically Relevant
Supporting innovation with real-world impact
CO-AX supports startups with ambitions to scale innovations that address real healthcare needs. The accelerator offers support in areas such as business development, product validation, regulatory strategy, access to capital and connections to healthcare and industry partners.
Stay tuned for upcoming Fall applications 2026 at CO-AX accelerator!
About CO-AX
The CO-AX Accelerator, based at Sahlgrenska Science Park, supports entrepreneurs developing technology-driven solutions to global health challenges. By combining deep sector expertise with a strong collaborative ecosystem, CO-AX helps startups accelerate growth and move innovations closer to real-world implementation in healthcare.